Company intelligence / Profile preview

Vanigent Biopharm

Atlanta, Georgia, United Statesvanigent.com ↗

Ownership: Private
Employees: ~200
Development stage: Phase 1

Overview

Vanigent Biopharm specializes in contract sales and commercialization solutions for pharmaceutical and biotech companies. The firm leverages decades of industry experience to support product launches, field deployment, sales force strategy, and lifecycle management. It does not conduct clinical trials or develop its own drug pipeline but partners with clients across the value chain to optimize commercial outcomes.

Industry: Consulting

Drug pipeline

5 assets

APVO436

Phase 1

Indications: Acute myelogenous leukemia

4 more assets in the full pipeline.

Request access →

Partnerships

Multiple partnerships with pharmaceutical and biotech companies for commercialization projects; specific partner names are not disclosed publicly.

Beyond the preview

Go deeper on Vanigent Biopharm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vanigent Biopharm.

Explore the full profile